These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20359665)

  • 1. Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity.
    Escalona A; Yáñez R; Pimentel F; Galvao M; Ramos AC; Turiel D; Boza C; Awruch D; Gersin K; Ibáñez L
    Surg Obes Relat Dis; 2010 Mar; 6(2):126-31. PubMed ID: 20359665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery.
    Schouten R; Rijs CS; Bouvy ND; Hameeteman W; Koek GH; Janssen IM; Greve JW
    Ann Surg; 2010 Feb; 251(2):236-43. PubMed ID: 19858703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve.
    Rodriguez-Grunert L; Galvao Neto MP; Alamo M; Ramos AC; Baez PB; Tarnoff M
    Surg Obes Relat Dis; 2008; 4(1):55-9. PubMed ID: 18201671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner.
    Escalona A; Pimentel F; Sharp A; Becerra P; Slako M; Turiel D; Muñoz R; Bambs C; Guzmán S; Ibáñez L; Gersin K
    Ann Surg; 2012 Jun; 255(6):1080-5. PubMed ID: 22534421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on: Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity.
    Brethauer SA
    Surg Obes Relat Dis; 2010 Mar; 6(2):131. PubMed ID: 20359666
    [No Abstract]   [Full Text] [Related]  

  • 6. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates.
    Gersin KS; Rothstein RI; Rosenthal RJ; Stefanidis D; Deal SE; Kuwada TS; Laycock W; Adrales G; Vassiliou M; Szomstein S; Heller S; Joyce AM; Heiss F; Nepomnayshy D
    Gastrointest Endosc; 2010 May; 71(6):976-82. PubMed ID: 20304396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal- jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity.
    Gersin KS; Keller JE; Stefanidis D; Simms CS; Abraham DD; Deal SE; Kuwada TS; Heniford BT
    Surg Innov; 2007 Dec; 14(4):275-8. PubMed ID: 18178916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.
    Koehestanie P; de Jonge C; Berends FJ; Janssen IM; Bouvy ND; Greve JW
    Ann Surg; 2014 Dec; 260(6):984-92. PubMed ID: 25072436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner.
    de Moura EG; Martins BC; Lopes GS; Orso IR; de Oliveira SL; Galvão Neto MP; Santo MA; Sakai P; Ramos AC; Garrido Júnior AB; Mancini MC; Halpern A; Cecconello I
    Diabetes Technol Ther; 2012 Feb; 14(2):183-9. PubMed ID: 21932999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety experience with the duodenal-jejunal bypass liner: an endoscopic treatment for diabetes and obesity.
    Betzel B; Koehestanie P; Aarts EO; Dogan K; Homan J; Janssen IM; Wahab PJ; Groenen MJ; Berends FJ
    Gastrointest Endosc; 2015 Nov; 82(5):845-52. PubMed ID: 25952090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of the endoscopic duodenal-jejunal bypass liner prototype in severe or morbidly obese subjects implanted for up to 3 years.
    Quezada N; Muñoz R; Morelli C; Turiel D; Hernández J; Pimentel F; Escalona A
    Surg Endosc; 2018 Jan; 32(1):260-267. PubMed ID: 28664427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases.
    Cohen RV; Schiavon CA; Pinheiro JS; Correa JL; Rubino F
    Surg Obes Relat Dis; 2007; 3(2):195-7. PubMed ID: 17386401
    [No Abstract]   [Full Text] [Related]  

  • 13. Is reimplantation of the duodenal-jejunal bypass liner feasible?
    Koehestanie P; Betzel B; Aarts EO; Janssen IM; Wahab P; Berends FJ
    Surg Obes Relat Dis; 2015; 11(5):1099-104. PubMed ID: 25979208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliopancreatic diversion with duodenal switch or gastric bypass for failed gastric banding: retrospective study from two institutions with preliminary results.
    Topart P; Becouarn G; Ritz P
    Surg Obes Relat Dis; 2007; 3(5):521-5. PubMed ID: 17903771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of the Weight-loss Endoscopy Trial (WET): a multi-center, randomized, controlled trial comparing weight loss in endoscopically implanted duodenal-jejunal bypass liners vs. intragastric balloons vs. a sham procedure.
    Hollenbach M; Prettin C; Gundling F; Schepp W; Seufert J; Stein J; Rösch T; Aberle J; Feisthammel J; Petroff D; Hoffmeister A
    BMC Gastroenterol; 2018 Jul; 18(1):118. PubMed ID: 30021518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantation of the duodenal-jejunal bypass sleeve under conscious sedation: a case series.
    Montaña R; Slako M; Escalona A
    Surg Obes Relat Dis; 2012; 8(5):e63-5. PubMed ID: 21955744
    [No Abstract]   [Full Text] [Related]  

  • 17. Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.
    Betzel B; Homan J; Aarts EO; Janssen IMC; de Boer H; Wahab PJ; Groenen MJM; Berends FJ
    Surg Endosc; 2017 Jul; 31(7):2881-2891. PubMed ID: 27804045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful endoscopic management of gastrojejunal anastomotic strictures after Roux-en-Y gastric bypass.
    Peifer KJ; Shiels AJ; Azar R; Rivera RE; Eagon JC; Jonnalagadda S
    Gastrointest Endosc; 2007 Aug; 66(2):248-52. PubMed ID: 17451700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation.
    Betzel B; Cooiman MI; Aarts EO; Janssen IMC; Wahab PJ; Groenen MJM; Drenth JPH; Berends FJ
    Surg Endosc; 2020 Jan; 34(1):209-215. PubMed ID: 30877567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight loss outcome of revisional bariatric operations varies according to the primary procedure.
    Brolin RE; Cody RP
    Ann Surg; 2008 Aug; 248(2):227-32. PubMed ID: 18650632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.